The University of Texas at Austin College of Pharmacy student will discuss how to captivate Gen Z with compounding.
Jennifer Lines, University of Texas at Austin College of Pharmacy Student
Houston, Oct. 14, 2024 (GLOBE NEWSWIRE) — PCCA has selected pharmacy student Jennifer Lines, PharmD candidate, from The University of Texas at Austin College of Pharmacy, as the winner of the 2024 PCCA Institute Pharmacy Student Scholarship Contest. Lines will deliver a 10-minute mainstage presentation on Saturday, October 19, during ThinkNext: International Seminar 2024. More than 500 compounders from the United States, Canada, Australia and beyond are expected to attend the compounding industry’s biggest event.
“Jennifer is a shining star and the future of compounding,” said PCCA Vice President of Public Affairs, Education and Human Relations Lizzie Harbin. “She recognizes what is needed to make compounding relevant for Gen-Z patients, practitioners and the community.”
A fourth-year pharmacy student earning her doctorate in pharmacy, Lines is also currently serving as a PCCA Clinical Services intern. During her presentation, she will discuss how personalized medicine will accommodate the needs and values of Gen-Z patients and prescribers.
“My generation, ‘Gen-Z,’ is the first truly digital generation. Our whole lives have been shaped by access to unlimited information,” Lines said. “How do we, as compounding pharmacists, break through the endless stream of content? The answer lies between how and where we meet my unique generation.”
Pharmacy students across the country entered the scholarship contest for the opportunity to engage with compounding pharmacists from around the world at ThinkNext. Contest participants were given the option to discuss Advocacy, Innovation or Business Development related to compounding pharmacies. Contest finalists also included Mollie Vergara, a pharmacy student from Northeast Ohio Medical University, and Bo Ewing, a pharmacy student from Lake Erie College of Osteopathic Medicine.
“I am extremely proud of all of our students and their remarkable contest applications,” said PCCA Director of Academic Affairs Bindhu Batra, PharmD, RPh. “This year, we look forward to engaging with even more pharmacy students at our ThinkNext: Student Day on Saturday, October 19, 2024. Students enrolled in a college of pharmacy will have the opportunity to learn more about compounding from our successful pharmacy members and PCCA staff.”
From October 17-19, compounders will converge in Houston and online to inspire and elevate their practices. ThinkNext: International Seminar 2024 attendees will increase their knowledge, discover strategies and gain access to new products and technology via keynotes by industry thought leaders, receive informative talks on new formulations, learn from panels on advocacy and compliance, explore equipment demos and more. For the agenda and registration details, visit pccainternationalseminar.com.
# # #
ABOUT PCCA
PCCA supports the creation of personalized medicine and innovative products that make a difference in patients’ lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years. Learn more at pccarx.com.
Attachment
- Jennifer Lines, University of Texas at Austin College of Pharmacy Student
CONTACT: Kim Speairs, APR, MBA PCCA 817-729-5064 [email protected]
- ROSEN, A GLOBAL AND LEADING FIRM, Encourages The Toronto-Dominion Bank Investors to Secure Counsel Before Important Deadline in Securities Class Action – TD - November 3, 2024
- ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Flux Power Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FLUX - November 3, 2024
- Complete Solar to Report Third Quarter Financial and Operational Results on November 13, 2024 - November 3, 2024